大参林涨2.05%,成交额6506.94万元,主力资金净流入167.05万元

Core Viewpoint - Dazhonglin's stock price has shown a positive trend in early 2025, with a notable increase in both revenue and net profit year-on-year, indicating a stable growth trajectory in the pharmaceutical retail sector [2][3]. Group 1: Stock Performance - As of January 14, Dazhonglin's stock price increased by 2.05%, reaching 18.91 CNY per share, with a trading volume of 65.07 million CNY and a turnover rate of 0.30% [1]. - Year-to-date, Dazhonglin's stock has risen by 7.32%, with a 4.36% increase over the last five trading days, an 8.99% increase over the last 20 days, and a 4.76% increase over the last 60 days [2]. Group 2: Company Overview - Dazhonglin Pharmaceutical Group Co., Ltd. was established on February 12, 1999, and went public on July 31, 2017. The company is based in Guangzhou, Guangdong Province [2]. - The company's main business includes the retail of traditional Chinese and Western medicines, health supplements, medical devices, and other products, with the revenue composition being 79.08% from Western and Chinese medicines, 10.87% from non-pharmaceuticals, and 10.05% from medicinal materials [2]. Group 3: Financial Performance - For the period from January to September 2025, Dazhonglin achieved a revenue of 20.068 billion CNY, reflecting a year-on-year growth of 1.71%, while the net profit attributable to shareholders was 1.081 billion CNY, marking a significant increase of 25.97% [2]. - Since its A-share listing, Dazhonglin has distributed a total of 3.740 billion CNY in dividends, with 2.009 billion CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, Dazhonglin had 28,600 shareholders, a decrease of 9.38% from the previous period, with an average of 39,833 circulating shares per shareholder, which is an increase of 10.35% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest, holding 84.9429 million shares, a reduction of 5.505 million shares compared to the previous period [3].